期刊文献+

汉黄芩素及其抑制物细胞周期蛋白依赖性激酶1对人脑胶质瘤干细胞作用机制的研究 被引量:3

A research of mechanism and effects of wogonin and its inhibitor cyclin-dependent kinase 1 on human glioma stem cells
下载PDF
导出
摘要 目的研究汉黄芩素及其抑制剂细胞周期蛋白依赖性激酶1(CDKl)对人脑胶质瘤干细胞(BGSCs)的作用机制。方法使用不同浓度的汉黄芩素(1、10、1000μmol/L)对BGSCs进行浸染,并设空白对照组。采用四甲基偶氮唑盐(M1fr)比色法检测汉黄芩素对BGSCs增殖的影响;采用逆转录一聚合酶链反应(RT—PCR)检测CDKlmRNA表达;同时检测脂质过氧化产物还原型谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和丙二醛(MDA)含量的变化。结果汉黄芩素对人BGSCs增殖具有明显的抑制作用,各剂量汉黄芩素组BGSCs增殖[吸光度(A)值]较空白对照组明显降低,随给药浓度增加,细胞生长抑制率(IR)较空白对照组逐渐增加,以汉黄芩素100tanol/L组作用更显著[A值:0.18±0.02比0.67±0.03,IR:(64.43±0.04)%比0,均P〈0.05];各剂量汉黄芩素组CDKlmRNA表达(A值)均较空白对照组有不同程度的提高,在10tanol/L、100~mol/L汉黄芩素组出现显著提高(0.378±0.061、0.733±0.081比0.125±0.019,均P〈0.05);脂质过氧化产物GSH(mg/g)、SOD(U/g)和MDA(nmol/g)在各个剂量汉黄芩素组与空白对照组比较差异均无统计学意义(GSH:474.51±38.63、479.67±15.89、481.17±36.41比487.00±28.53.SOD:26.58±2.26、26.75±1.96、27.08±1.52比27.31±1.89,MDA:4.92±0.45、4.72±0.73、4.61±0.47比4.45±0.26,均P〉0.05)。结论CDKl可能参与汉黄芩素抑制人BGSCs生长的作用机制,该作用与脂质过氧化产物无关。 Objective To investigate the meclaanism and effects of wogonin and its inhibitor cyclin- dependent kinase 1 (CDK1) on human brain glioma stem cells (BGSCs). Methods BGSCs were treated with different concentrations ( 1,10,100 μmol/L) of wogonin and a blank control group was made. Cell growth inhibition of BGSCs was detected by assay of methyl thiazolyl tetrazolium (MTT). Expression of CDK1 mRNA was detected by retro transcriptive-polymerase chain reaction ( RT-PCR). Simultaneously, lipid peroxidation products of glutathione ( GSH ), superoxide dismutase (SOD), malondiadehyde (MDA) were tested. Results Wogonin significantly suppressed the growth of BGSCs [ absorbance (A) value ], statistical significant differences were found in study groups compared with blank control group. The cell growth inhibition rate (IR) was gradually increased with the administration of wogonin concentration increment, especially prominent in the wogonin 100 μmol/L group (A value : 0.18±0.02 vs. 0.67 + 0.03, IR : (64.43 + 0.04) % vs. 0, both P〈 0.05). Expression of CDK1 mRNA was significantly increased in 10 tmaol/L and 100 μmol/L wogonin groups compared to that in the blank control group (0.378 +0.061,0.733-4-0.081 vs. 0.125 +0.019, both P〈0.05). There was no significant change in GSH (mg/g), SOD (U/g) and MDA (nmol/g) in all groups (GSH: 474.51+38.63, 479.67+15.89, 481.17+36.41 vs. 487.00+28.53, SOD: 26.58+2.26, 26.75 + 1.96,27.08 -4- 1.52 vs. 27.31 + 1.89, MDA : 4.92 + 0.45,4.72 + 0.73,4.61 + 0.47 vs. 4.45 + 0.26, all P 〉 0.05 ). Conclusion CDK1 possibly participates in the mechanism of wogonin suppression of BGSCs growth which is not related to lipid oeroxidation.
出处 《中国中西医结合急救杂志》 CAS 北大核心 2013年第3期142-145,共4页 Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
基金 国家自然科学基金青年基金(11102235) 天津市自然科学基金重点项目(12JCZDJC24100) 武警医学院科研基金面上项目(WYM201118) 武警医学院科研基金博士启动金项目(WYB201110)
关键词 汉黄芩素 细胞周期蛋白依赖性激酶1 脑胶质瘤干细胞 Wogonin Cyclin-dependent kinase 1 Glioma stem cells
  • 相关文献

参考文献13

二级参考文献38

共引文献39

同被引文献32

  • 1朱慧民,石涵,樊锦秀,陈雅.赤芍对颈动脉球囊损伤术后兔血管内膜增生的干预作用研究[J].中国中西医结合急救杂志,2008,15(6):332-337. 被引量:3
  • 2刘力戈,阎田玉.热毒净治疗传染性单核细胞增多症46例[J].中医杂志,1993,34(11):669-670. 被引量:9
  • 3胡亚美,江载芳主编.诸福堂实用儿科学[M].8版.北京:人民卫生出版社,2012:689-690.
  • 4马融,韩新民.中医儿科学[M].2版.北京:人民卫生出版社,2012:158.
  • 5Eligio P, Delia R, Valeria G. EBV Chronic Infections [ J ]. Mediterr J Hematol Infect Dis, 2010, 2 ( 1 ) : e2010022.
  • 6Henter JI, Home A, Arico M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lyraphohistice.ytosis [ J ]. Pediatr Blood Cancer, 2007, 48 (2) : 124-13 I.
  • 7贾劬,周玲.杨跃煌.传染性单核细胞增多症121例[J].中华传染病杂志,2001.19(2):122.
  • 8董幼琪,董继业.董氏儿科[M].北京:中国中医药出版社.2013:385.
  • 9卢伟,陈德明.吕启圣,等.活血化瘀法为主治疗传染性单核细胞增多症27例[J].中西医结合杂志,1989,9(4):233.
  • 10简永耀,靳龙文.连翘的化学成分及药理学研究[J].淮海医药,2009,27(4):349-350. 被引量:47

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部